Tetrabuthylammonium

Tetrabuthylammonium

SCHEMBL1800283

CCCC[N+](CCCC)(CCCC)CCCC.[B].[H-]

nearest known ligand 0.86

Full drug profile on Sugi Atlas →

Predicted protein targets (top 12)

geneUniProtsupporting neighboursconfidence
▸ SLC22A1 O15245 4/20 0.86
▸ SLC22A2 O15244 1/20 0.73
▸ TSHR P16473 2/20 0.65
▸ ALDH1A1 P00352 1/20 0.65
▸ TP53 P04637 1/20 0.65
▸ CYP3A4 P08684 1/20 0.65
▸ ALOX15 P16050 1/20 0.65
▸ ALOX12 P18054 1/20 0.65
▸ SMN1; SMN2 Q16637 1/20 0.65
▸ HIF1A Q16665 1/20 0.65
▸ HSD17B10 Q99714 1/20 0.65
▸ DNM1 Q05193 6/20 0.58

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Tetrabuthylammonium SCHEMBL1250868 0.96 SLC22A1 (0.92) SLC22A1SLC22A2TSHRALDH1A1TP53
Tetrabuthylammonium SCHEMBL4056559 0.93 SLC22A1 (0.86) SLC22A1SLC22A2TSHRALDH1A1TP53
Tetrabuthylammonium SCHEMBL6622741 0.93 SLC22A1 (0.86) SLC22A1SLC22A2TSHRALDH1A1TP53
Tetrabuthylammonium SCHEMBL71525 0.93 SLC22A1 (1.00) SLC22A1SLC22A2TSHRALDH1A1TP53
Tetrabuthylammonium SCHEMBL22384 0.93 SLC22A1 (1.00) SLC22A1SLC22A2TSHRALDH1A1TP53
Tetrabuthylammonium SCHEMBL2007037 0.93 SLC22A1 (1.00) SLC22A1SLC22A2TSHRALDH1A1TP53
Tetrabuthylammonium SCHEMBL7970993 0.90 SLC22A1 (0.80) SLC22A1SLC22A2TSHRALDH1A1TP53
Tetrabuthylammonium SCHEMBL25266692 0.89 SLC22A1 (0.92) SLC22A1SLC22A2TSHRALDH1A1TP53
Tetrabuthylammonium SCHEMBL21980 0.89 SLC22A1 (0.92) SLC22A1SLC22A2TSHRALDH1A1TP53
Tetrabuthylammonium SCHEMBL37663 0.89 SLC22A1 (0.92) SLC22A1SLC22A2TSHRALDH1A1TP53

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 15 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-110536931-A Polycarbonate resin composition containing glass filler and molded article thereof IDEMITSU KOSAN CO 2019-12-03 — — CN disclosed
CN-109071789-A Copolycarbonate, using its optical lens and film and the copolymer manufacturing method 三菱瓦斯化学株式会社 2018-12-21 — — CN disclosed
CN-107840857-A A kind of silicon cyanation method of boron hydride catalysis ketone 杭州师范大学 2018-03-27 — — CN disclosed
EP-1889826-B1 METHOD FOR PRODUCING A HEXAHYDROFUROFURANOL DERIVATIVE SUMITOMO CHEMICAL CO (JP) 2011-10-26 — — EP disclosed
US-7951977-B2 Process for producing hexahydrofurofuranol derivative SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2011-05-31 — — US disclosed
US-20090176999-A1 Process for producing hexahydrofurofuranol derivative SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2009-07-09 — — US disclosed
EP-1889826-A1 METHOD FOR PRODUCING HEXAHYDROFUROFURANOL DERIVATIVE Sumitomo Chemical Company, Limited (JP) 2008-02-20 — — EP disclosed
CN-1668806-A Treatment of a mixture containing cellulose with a reducing agent BORREGAARD CHEMCELL (NO) 2005-09-14 — — CN disclosed
CN-1479716-A Propionic acid derivatives with PPAR-alpha activating properties — 2004-03-03 — — CN disclosed
EP-0629620-B1 New photochromic Naphto(2,1-b)pyrans and method for their preparation GREAT LAKES CHEMICAL EUROP (CH) 2002-04-17 — — EP disclosed
EP-1169292-A1 CYCLIC COMPOUNDS AND THEIR USE AS PRECURSORS OF FRAGRANT ALCOHOLS Firmenich S.A. (CH) 2002-01-09 — — EP disclosed
WO-2000058260-A1 CYCLIC COMPOUNDS AND THEIR USE AS PRECURSORS OF FRAGRANT ALCOHOLS FIRMENICH S.A. (CH) 2000-10-05 — — WO disclosed
EP-0816316-A1 PROCESS FOR PRODUCING 1,2-ETHANEDIOL DERIVATIVES NITTO CHEMICAL INDUSTRY CO., LTD. (JP) 1998-01-07 — — EP disclosed
US-5543533-A DEVELOP INTENSE YELLOW, YELLOW-ORANGE OR REDDISH COLORING WHEN EXPOSED TO LIGHT; LENSES GREAT LAKES CHEMICAL ITALIA S.R.L. (IT) 1996-08-06 — — US disclosed
EP-0629620-A1 New photochromic Naphto(2,1-b)pyrans and method for their preparation GREAT LAKES CHEMICAL ITALIA S.r.l. (IT) 1994-12-21 — — EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090176999-A1 Process for producing hexahydrofurofuranol derivative DHFR, DHPS, CYP4B1 SLC22A1 3568/4885SLC22A2 2947/4885TSHR 1193/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback